AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MeVis Medical Solutions AG

Earnings Release Feb 14, 2012

287_rns_2012-02-14_2851e935-dca7-460b-bc51-206ecc90642c.html

Earnings Release

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 14 February 2012 07:49

MeVis Medical Solutions AG announces preliminary figures for 2011

MeVis Medical Solutions AG / Key word(s): Preliminary Results/Profit Warning

14.02.2012 07:49

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


EBITDA and EBIT above prior year - but EBIT burdened by mainly non-cash,
one-time charges

Bremen, February 14, 2012 - MeVis Medical Solutions AG [ISIN:
DE000A0LBFE4], a leading software provider for the medical imaging market,
has achieved based on preliminary figures, a Group turnover for fiscal year
2011 of approx. EUR 13.7 million (previous year: EUR 14.3 million) and an
EBITDA of around EUR 4.1 million (previous year: EUR 3.5 million). The
Group EBIT of approx. EUR -1.7 million (previous year: EUR -5.4 million)
was burdened by mainly non-cash, one-time charges. Compared to the previous
year, Group EBIT before one-time charges was improved by approx. EUR 0.2
million to approx. EUR 0.9 million.

The one-time charges impacting the EBIT consist of a non-cash impairment
charge on intangible assets in the amount of approx. EUR 2.3 million for
capitalized development expenses of Visia Software Applications since 2008.
In addition, a provision has been made for the contractual obligations to
the CEO, Dr. Carl Evertsz, who will leave the company on February 29, 2012.

The financial result was impacted by a partial write-off of the 41% stake
in the Dutch company Medis in the amount of EUR 0.9 million. This non-cash
write-off was due to an adjusted assessment of the future development.

On December 31, 2011 the Group's liquidity amounted to EUR 7.6 million.
Liquidity therefore decreased by just EUR 0.6 million, despite a EUR 3.0
million payment in 2011 for the acquisition of the 49% stake in the MBS KG
in 2008.

The complete consolidated financial statement, the Group management report
and the forecast for the current fiscal year will be released on April 24,
2012.

14.02.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: MeVis Medical Solutions AG
Universitätsallee 29
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 11
E-mail: [email protected]
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, München, Stuttgart

End of Announcement DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.